Major Thalassemia, Screening or Treatment: An Economic Evaluation Study in Iran
BackgroundBeta-thalassemia minor and thalassemia major are an autosomal recessive disease with hypochromic, microcytic anemia, and morbidities, Today, therapeutic advances have significantly improved the life expectancy of thalassemia major patients, but at the cost of financial toxicity. The presen...
Main Authors: | Firooz Esmaeilzadeh, Batoul Ahmadi, Sajad Vahedi, Saeed Barzegari, Abdolhalim Rajabi |
---|---|
Format: | Article |
Language: | English |
Published: |
Kerman University of Medical Sciences
2022-07-01
|
Series: | International Journal of Health Policy and Management |
Subjects: | |
Online Access: | https://www.ijhpm.com/article_4008_9455b9f75398c3a4ed7f0832856458c2.pdf |
Similar Items
-
Evaluation of Factors influencing the birth of Thalassemia in Family Members with Thalassemia Major in Southeast Iran in 2021
by: Majid Naderi, et al.
Published: (2023-03-01) -
Premarital screening test results for beta thalassemia in Malatya Province
by: Mehmet Erten
Published: (2021-09-01) -
QUALITY OF LIFE IN PATIENTS WITH THALASSEMIA MAJOR AND INTERMEDIA IN KERMAN-IRAN (I.R.)
by: Hossein Safizadeh, et al.
Published: (2012-10-01) -
The inverse correlation between serum levels of anti-pneumococcal and ferritin after pneumococcal vaccination in splenectomised beta thalassemia major
by: Karamatollah Rahmanian, et al.
Published: (2022-06-01) -
Adrenal Insufficiency in Patients with Beta-Thalassemia Major in the Southeast of Iran
by: Ghasem Miri-Aliabad, et al.
Published: (2022-07-01)